KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesDividends payablesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abbott Laboratories (ABT) Treasury Shares (2016 - 2026)

Abbott Laboratories' Treasury Shares history spans 18 years, with the latest figure at $16.9 billion for Q1 2026.

  • On a quarterly basis, Treasury Shares rose 1.94% to $16.9 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $16.9 billion, a 1.94% increase, with the full-year FY2025 number at $17.2 billion, up 1.98% from a year prior.
  • Treasury Shares hit $256.4 million in Q1 2026 for Abbott Laboratories, down from $260.2 million in the prior quarter.
  • Over the last five years, Treasury Shares for ABT hit a ceiling of $260.2 million in Q4 2025 and a floor of $234.5 million in Q2 2022.
  • Historically, Treasury Shares has averaged $251.1 million across 5 years, with a median of $251.8 million in 2023.
  • Biggest five-year swings in Treasury Shares: soared 39.42% in 2022 and later grew 0.24% in 2024.
  • Tracing ABT's Treasury Shares over 5 years: stood at $15.2 billion in 2022, then rose by 4.94% to $16.0 billion in 2023, then rose by 5.4% to $16.8 billion in 2024, then rose by 1.98% to $17.2 billion in 2025, then fell by 1.41% to $16.9 billion in 2026.
  • Business Quant data shows Treasury Shares for ABT at $16.9 billion in Q1 2026, $17.2 billion in Q4 2025, and $16.9 billion in Q3 2025.